Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Mar Biotechnol (NY)
2009 Jan 01;115:557-62. doi: 10.1007/s10126-008-9170-1.
Show Gene links
Show Anatomy links
Inhibitory effects of Fucoidan in 3T3-L1 adipocyte differentiation.
Kim MJ
,
Chang UJ
,
Lee JS
.
???displayArticle.abstract???
Fucoidan is a group of sulfated fucose-containing polysaccharides that derived from non-mammalian origin such as marine brown algae, the jelly coat from sea urchin eggs, and the sea cucumber body wall. However, potential biological activities against obesity from fucoidan were not reported in the literature. The objective of this study was to evaluate protective effect of fucoidan in 3T3-L1 adipocyte differentiation. Preadipocyte 3T3-L1 was treated with 100 and 200 microg/ml fucoidan during adipogenesis. Adipogenesis was determined through Oil Red O staining method and the expression of adipogenic genes aP2, ACC, and PPARgamma. Adipogenesis of 3T3-L1 treated with 100 and 200 microg/ml fucoidan were significantly inhibited at 32.8% and 39.7% using Oil Red O staining method, respectively (P < 0.05). Treating the 3T3-L1 cells with 100 and 200 microg/ml fucoidan significantly decreased the expression of aP2 gene by 6.2% and 27.2%, respectively, of ACC gene by 22.2% and 38.2%, respectively, and of PPARgamma gene by 44.2% and 69.4%, respectively, compared to adipocyte controls (P < 0.05). The results suggest that fucoidan could be used for inhibiting fat accumulation, which is mediated by decreasing aP2, ACC, and PPARgamma gene expression.
Aisa,
Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways.
2005, Pubmed
Aisa,
Fucoidan induces apoptosis of human HS-sultan cells accompanied by activation of caspase-3 and down-regulation of ERK pathways.
2005,
Pubmed
Blondin,
Relationships between chemical characteristics and anticomplementary activity of fucans.
1996,
Pubmed
Béress,
A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucus vesiculosus.
1993,
Pubmed
Haroun-Bouhedja,
Relationship between sulfate groups and biological activities of fucans.
2000,
Pubmed
Hsu,
Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways.
2001,
Pubmed
Inazawa,
Lipid droplet formation in human myeloid NB4 cells stimulated by all trans retinoic acid and granulocyte colony-stimulating factor: possible involvement of peroxisome proliferator-activated receptor gamma.
2003,
Pubmed
Kawada,
Biochemical and physiological characteristics of fat cell.
2001,
Pubmed
Lee,
The proteomic analysis of an adipocyte differentiated from human mesenchymal stem cells using two-dimensional gel electrophoresis.
2006,
Pubmed
Liu,
Inhibitory effect of fucoidan on the adhesion of adenocarcinoma cells to fibronectin.
2005,
Pubmed
Mauray,
Venous antithrombotic and anticoagulant activities of a fucoïdan fraction.
1995,
Pubmed
McGarry,
The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis.
1997,
Pubmed
McLellan,
Anticoagulants from marine algae.
1992,
Pubmed
Nakamura,
Fucoidan induces nitric oxide production via p38 mitogen-activated protein kinase and NF-kappaB-dependent signaling pathways through macrophage scavenger receptors.
2006,
Pubmed
Nakano,
Antagonism of peroxisome proliferator-activated receptor gamma prevents high-fat diet-induced obesity in vivo.
2006,
Pubmed
Nishino,
Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome.
1991,
Pubmed
Patankar,
A revised structure for fucoidan may explain some of its biological activities.
1993,
Pubmed
Rangwala,
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
2004,
Pubmed
SPRINGER,
Isolation of anticoagulant fractions from crude fucoidin.
1957,
Pubmed
Sharma,
Adipose tissue: a mediator of cardiovascular risk.
2002,
Pubmed
Shimomura,
Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy.
1998,
Pubmed
Tontonoz,
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
1994,
Pubmed
WAITE,
Studies on the mechanism of action of acetyl coenzyme A carboxylase. I. Effect of isocitrate on the transcarboxylation step of acetyl coenzyme A carboxylase.
1963,
Pubmed
Wakil,
Fatty acid synthase, a proficient multifunctional enzyme.
1989,
Pubmed
Willson,
Peroxisome proliferator-activated receptor agonists.
1997,
Pubmed
Yamauchi,
The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance.
2001,
Pubmed
Yang,
Bifunctional effects of fucoidan on the expression of inducible nitric oxide synthase.
2006,
Pubmed
